Log In
Sign Up
All-trans Retinoic Acid
Indications
Induction of remission in patients with acute promyelocytic leukemia.
Dose/Application
45mg/m2/day [in 2 divided doses]. To be stopped either 30 days after full remission or after 90 days of treatment [whichever is achieved first].
Mode of action
Precautions
Contraindications
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us